Jeffrey Farrow has served as an Achieve Life Sciences director since 2026, chairing the Audit Committee and serving on the Nominating and Governance Committee. He has been Chief Financial Officer and Chief Strategy Officer of Tarsus Pharmaceuticals since April 2023 and previously served as Chief Financial Officer of Global Blood Therapeutics (2016-2022, acquired by Pfizer), ZS Pharma (acquired by AstraZeneca in 2015) and Hyperion Therapeutics (acquired by Horizon Therapeutics in 2015), and earlier as vice president of finance at Evotec AG and vice president of finance and Chief Accounting Officer at Renovis, Inc. He began his career in the audit practice of KPMG LLP. Mr. Farrow holds a B.A. in business administration from California State University at Fullerton and is a certified public accountant (inactive).